Skip to main content
Premium Trial:

Request an Annual Quote

Liebman Leaves Wyeth to Head Roche's Global Computational Genetics

Premium

PALO ALTO, Calif.--Michael Liebman last week left his position as director of biomedical informatics and pharmaco-genomics at Wyeth-Ayerst Research in Radnor, Pa., to become director of computational biology and global head of computational genetics for Roche Bioscience here. Liebman spent two years at Wyeth, and previously directed bioinformatics and genomics for Vysis. Liebman continues to hold professorships at Northwestern University in chemical engineering and at the university's Center for Biotechnology, and is a professor of biochemistry at Loyola University in Chicago.

Liebman told BioInform he expects his new position at Roche to "provide unique opportunities to start looking at the relationship between diagnostics and therapeutics, which is going to be managed through the integration of genetics and genomics, and which will play a major role in the future of medicine."

Filed under

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.